Latin America, Middle East & Africa Clinical Trial Supplies Market Databank
The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical device segment is anticipated to reach $959.0 Million by 2029 with the highest CAGR of 7.58%. Pharmaceutical and Medical device segments collectively expected to account for about 70.4% share of the Clinical Trial Supplies market in 2020, with the former constituting around 46.5% share. Medical device and Biologics segments are expected to witness significant growth rates at a CAGR of 7.58% and 7.53% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 38.4% in the overall Clinical Trial Supplies market in 2020, and is anticipated to reach 38.6% by 2029.
- 1. GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY END USE
- 1.1. OVERVIEW
- 1.2. PHARMACEUTICAL
- 1.2.1 PHARMACEUTICAL MARKET, BY REGION
- 1.2.1.1 North America Pharmaceutical Market, By Country
- 1.2.1.2 Europe Pharmaceutical Market, By Country
- 1.2.1.3 Asia-Pacific Pharmaceutical Market, By Country
- 1.2.1.4 Latin America, Middle East & Africa Pharmaceutical Market, By Country
- 1.3. BIOLOGICS
- 1.3.1 BIOLOGICS MARKET, BY REGION
- 1.3.1.1 North America Biologics Market, By Country
- 1.3.1.2 Europe Biologics Market, By Country
- 1.3.1.3 Asia-Pacific Biologics Market, By Country
- 1.3.1.4 Latin America, Middle East & Africa Biologics Market, By Country
- 1.4. MEDICAL DEVICE
- 1.4.1 MEDICAL DEVICE MARKET, BY REGION
- 1.4.1.1 North America Medical device Market, By Country
- 1.4.1.2 Europe Medical device Market, By Country
- 1.4.1.3 Asia-Pacific Medical device Market, By Country
- 1.4.1.4 Latin America, Middle East & Africa Medical device Market, By Country
- 1.5. OTHER END USES
- 1.5.1 OTHER END USES MARKET, BY REGION
- 1.5.1.1 North America Other End uses Market, By Country
- 1.5.1.2 Europe Other End uses Market, By Country
- 1.5.1.3 Asia-Pacific Other End uses Market, By Country
- 1.5.1.4 Latin America, Middle East & Africa Other End uses Market, By Country
- 2. GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE
- 2.1. OVERVIEW
- 2.2. PHASE I
- 2.2.1 PHASE I MARKET, BY REGION
- 2.2.1.1 North America Phase I Market, By Country
- 2.2.1.2 Europe Phase I Market, By Country
- 2.2.1.3 Asia-Pacific Phase I Market, By Country
- 2.2.1.4 Latin America, Middle East & Africa Phase I Market, By Country
- 2.3. PHASE II
- 2.3.1 PHASE II MARKET, BY REGION
- 2.3.1.1 North America Phase II Market, By Country
- 2.3.1.2 Europe Phase II Market, By Country
- 2.3.1.3 Asia-Pacific Phase II Market, By Country
- 2.3.1.4 Latin America, Middle East & Africa Phase II Market, By Country
- 2.4. PHASE III
- 2.4.1 PHASE III MARKET, BY REGION
- 2.4.1.1 North America Phase III Market, By Country
- 2.4.1.2 Europe Phase III Market, By Country
- 2.4.1.3 Asia-Pacific Phase III Market, By Country
- 2.4.1.4 Latin America, Middle East & Africa Phase III Market, By Country
- 2.5. OTHER CLINICAL PHASES
- 2.5.1 OTHER CLINICAL PHASES MARKET, BY REGION
- 2.5.1.1 North America Other Clinical Phases Market, By Country
- 2.5.1.2 Europe Other Clinical Phases Market, By Country
- 2.5.1.3 Asia-Pacific Other Clinical Phases Market, By Country
- 2.5.1.4 Latin America, Middle East & Africa Other Clinical Phases Market, By Country
- 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY REGION
- 3.1. OVERVIEW
- 3.2. LATIN AMERICA, MIDDLE EAST & AFRICA
- 3.2.1 LATIN AMERICA, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY END USE
- 3.2.2 LATIN AMERICA, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE
- 3.2.3 LATIN AMERICA, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY
- 3.2.3.1 Brazil
- 3.2.3.1.1 Brazil Clinical Trial Supplies Market, By End use
- 3.2.3.1.2 Brazil Clinical Trial Supplies Market, By Clinical Phase
- 3.2.3.2 South Africa
- 3.2.3.2.1 South Africa Clinical Trial Supplies Market, By End use
- 3.2.3.2.2 South Africa Clinical Trial Supplies Market, By Clinical Phase
- 3.2.3.3 GCC
- 3.2.3.3.1 GCC Clinical Trial Supplies Market, By End use
- 3.2.3.3.2 GCC Clinical Trial Supplies Market, By Clinical Phase
- 3.2.3.4 Latin America, Middle East & Africa Countries
- 3.2.3.4.1 Latin America, Middle East & Africa Countries Clinical Trial Supplies Market, By End use
- 3.2.3.4.2 Latin America, Middle East & Africa Countries Clinical Trial Supplies Market, By Clinical Phase
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook